Evaluation of commercial Anti-SARS-CoV-2 neutralizing antibody assays in seropositive subjects
혈청 양성 환자에서 상업용 Anti-SARS-CoV-2 중화 항체 분석 평가
Article
[키워드] absence
added
addition
anti-RBD
Anti-RBD antibodies
Anti-RBD antibody
anti-spike antibody
anti-Spike IgG
antibody
Antibody titer
Area
bioMérieux
cells
cellular receptor
Commercial tests
Competitive anti-RBD immunoassays
correlation
difficulty
functional
highlight
house
immunoassay
immunoassays
immunochromatographic test
Interaction
marker
NAb titer
NAb titers
neutralization test
Neutralizing antibodies
neutralizing antibody
neutralizing antibody assay
New
P-value
patients
plaque reduction neutralization
PRNT
qualitative test
Quantitative
reduction
SARS-CoV-2
SARS-CoV-2 entry
Sensitivity and specificity
sera
seropositive subject
seropositive subjects
Spike protein
surrogate
surrogate markers
Surrogate markers of protection.
sVNT
tested
the spike protein
threshold
thresholds
titer
variants of concern
virus neutralization test
VNT
VoC
[DOI] 10.1016/j.jcv.2022.105169 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.jcv.2022.105169 PMC 바로가기 [Article Type] Article